VCR ventracor limited


  1. 423 Posts.
    Sep 05, 2003 (The West Australian - ABIX via COMTEX) -- Ventracor has announced a one-for-12 rights issue set at $A2.25 per share. A week after it raised $A33.7m via an institutional placement, also at $A2.25, it wants to raise another $A33m to help pay for the commercialisation of its artificial heart product, VentrAssist. Meanwhile, Prana Biotechnology has arranged a placement of up to 7.1 million shares at $A0.70 each to Peregrine Corporate's clients. It will use the $A5m it hopes to raise to fund trials of its Alzheimer's vaccine.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.